Clinical Trial Update: SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating an SGLT2 inhibitor for Type 2 diabetes, noting potential safety concerns such as ketoacidosis, volume depletion, and in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING